# Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease

> **NCT02742337** · — · UNKNOWN · sponsor: **Arthritis Northwest PLLC** · enrollment: 30 (estimated)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02742337
- **Lead sponsor:** Arthritis Northwest PLLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2016-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02742337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02742337, "Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02742337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
